{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"121","value":"422"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"description":"Evaluation of pharmacokinetics (Pk) of veltuzumab and milatuzumab was performed for patients included in the trial. Statistically, descriptive data of PK parameters will be computed. Relationships between such parameters as dose and AUC, volume of distribution, clearance, and others will be evaluated, but be preliminary due to the small sample size.","dispersionType":"Standard Deviation","groups":[{"description":"First dose milatuzumab pharmacokinetics for patients doses at 20 mg/kg","id":"OG000","title":"Patients Dosed at 20mg/kg"}],"paramType":"MEAN","populationDescription":"AUC0-∞ for patients dosed at 20 mg/kg","reportingStatus":"POSTED","timeFrame":"0, 24, 48, 72, 96 and 120 hours post-does","title":"Access Pharmacokinetics Through AUC0-∞ (Area Under Curve)","type":"SECONDARY","unitOfMeasure":"d*ug/ml"}